chloroquine has been researched along with oxytetracycline, anhydrous in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (60.00) | 18.7374 |
1990's | 1 (4.00) | 18.2507 |
2000's | 3 (12.00) | 29.6817 |
2010's | 4 (16.00) | 24.3611 |
2020's | 2 (8.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Mishra, AK; Sharma, NN | 1 |
Ahuja, RC; Chandar, V; Johri, S; Mehta, SR; Naidu, G; Singh, IP | 1 |
Henderson, A; McCallum, J; Melia, W; Navein, J; Simon, J | 1 |
Mehta, SR | 1 |
Peters, W | 1 |
Dawkins, AT; Stahler, N; Terzian, LA | 1 |
Huggins, D | 1 |
Clyde, DF; DuPont, HL; Hornick, RB; Miller, RM | 1 |
Jones, TO | 1 |
Seaton, DR | 1 |
Rautenstrauch, H | 1 |
Ellis, SM; Koeleman, HA; Steyn, HS; Wessels, JC | 1 |
TUCKER, WH | 1 |
CASANOVA ARZOLA, R; MORENO, O; PEREA CORRAL, J; VALDES GUTIERREZ, O | 1 |
ABD-EL-GHAFFAR, V | 1 |
BRACKEN, EC | 1 |
Ma, C; Wang, J | 1 |
Huang, YY; Li, Z; Lin, Y; Liu, R; Luo, HB; Wang, X; Zhan, CG | 1 |
3 review(s) available for chloroquine and oxytetracycline, anhydrous
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Summary of recent abstracts. 3. Malaria. 2.
Topics: Animals; Antimalarials; Birds; Chloroquine; Dapsone; Humans; India; Malaria; Malaria, Avian; Mammals; Naphthoquinones; Oxytetracycline; Plasmodium; Plasmodium falciparum; Quinacrine; Rats; Reptiles | 1972 |
[Management of parasitic intestinal diseases].
Topics: Amebicides; Anthelmintics; Balantidiasis; Brazil; Chloroquine; Chloroquinolinols; Dysentery, Amebic; Emetine; Furazolidone; Giardiasis; Humans; Intestinal Diseases, Parasitic; Metronidazole; Oxytetracycline; Paromomycin; Quinolines | 1968 |
22 other study(ies) available for chloroquine and oxytetracycline, anhydrous
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparative efficacy of drugs in bovine anaplasmosis.
Topics: Amodiaquine; Anaplasmosis; Animals; Anti-Infective Agents; Body Temperature; Cattle; Cattle Diseases; Chloroquine; Chlortetracycline; Imidocarb; Oxytetracycline; Tetracycline | 1979 |
Falciparum malaria--present day problems. An experience with 425 cases.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Chloroquine; Female; Humans; India; Infant; Infant, Newborn; Malaria; Male; Middle Aged; Oxytetracycline; Plasmodium falciparum | 1989 |
Polyresistant malaria in Gurkha soldiers returning from Papua New Guinea: treatment and prevention.
Topics: Antimalarials; Chloroquine; Drug Resistance, Microbial; Ethnicity; Hong Kong; Humans; Malaria; Male; Military Personnel; Nepal; Oxytetracycline; Papua New Guinea; Plasmodium falciparum; Plasmodium vivax; Primaquine; Proguanil; Quinine; United Kingdom | 1986 |
Falciparum malaria--210 cases.
Topics: Adolescent; Adult; Child; Chloroquine; Drug Combinations; Female; Humans; India; Malaria; Male; Middle Aged; Oxytetracycline; Plasmodium falciparum; Plasmodium vivax | 1986 |
The sporogonous of Plasmodium vivax in Anopheles mosquitoes as a system for evaluating the prophylactic and curative capabilities of potential antimalarial compounds.
Topics: Animals; Anopheles; Antimalarials; Chloroquine; Malaria; Naphthoquinones; Oxytetracycline; Penicillin G; Plasmodium vivax; Primaquine; Proguanil; Pyridines; Pyrimethamine; Quinacrine; Quinine; Quinolines; Sulfadiazine; Thiosemicarbazones | 1968 |
Antimalarial effects of tetracyclines in man.
Topics: Adult; Body Temperature; Chloroquine; Doxycycline; Humans; Malaria; Male; Middle Aged; Oxytetracycline; Plasmodium falciparum; Plasmodium vivax; Tetracycline; Time Factors | 1971 |
Treatment of East Coast fever.
Topics: Animals; Cattle; Chloroquine; Drug Synergism; Male; Oxytetracycline; Theileriasis | 1971 |
Amoebicides.
Topics: Amebicides; Chloroquine; Dysentery, Amebic; Emetine; Humans; Imidazoles; Metronidazole; Oxytetracycline | 1971 |
[Diffuse interstitial pulmonary fibrosis (Hamman-Rich syndrome) and primary chronic polyarthritis].
Topics: Adult; Arthritis, Rheumatoid; Chloroquine; Chronic Disease; Female; Humans; Oxytetracycline; Phosphates; Prednisone; Pulmonary Fibrosis | 1971 |
The application of new bioavailability parameters in the bioequivalence testing of antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Biological Availability; Chloroquine; Floxacillin; Humans; Microbial Sensitivity Tests; Oxytetracycline; Penicillins; Therapeutic Equivalency | 1993 |
Treatment and prognosis of amebiasis.
Topics: Amebiasis; Amebicides; Arsenicals; Bismuth; Chloroquine; Dysentery, Amebic; Intestines; Oxytetracycline; Prognosis | 1953 |
[Amebic liver abscess in an infant; report of a cured case].
Topics: Amebiasis; Child; Chloroquine; Dysentery, Amebic; Humans; Infant; Liver Abscess, Amebic; Oxytetracycline | 1956 |
Successful treatment of hepatic and splenic amebic abscesses with atabrine after failure of emetine, chloroquine and terramycin.
Topics: Amebiasis; Chloroquine; Disease; Dysentery, Amebic; Emetine; Humans; Liver Abscess; Oxytetracycline; Quinacrine; Spleen | 1960 |
ANTIHELMINTHIC THERAPY: A SIMPLIFIED APPROACH.
Topics: Amebiasis; Anthelmintics; Ascariasis; Chloroquine; Dysentery, Amebic; Giardiasis; Hookworm Infections; Humans; Oxytetracycline; Quinacrine; Strongyloidiasis; Trichinellosis | 1964 |
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Pharmaceutical Preparations; Protease Inhibitors; Quinolines; SARS-CoV-2; Sulfides; Tetrazoles | 2021 |
Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
Topics: Acetates; Atazanavir Sulfate; Benzimidazoles; Biphenyl Compounds; Chloroquine; COVID-19 Drug Treatment; Cyclopropanes; Dipyridamole; Humans; Oxytetracycline; Protease Inhibitors; Quinolines; Reproducibility of Results; SARS-CoV-2; Sulfides; Tetrazoles | 2021 |